BioLineRx is a clinical-stage biopharmaceutical company focused on oncology. The Company in-licenses novel compounds, develops them through pre-clinical and/or clinical stages, and then partners with pharmaceutical companies for advanced clinical development and/or commercialization.

BioLineRx's leading therapeutic candidates are: BL-8040, a cancer therapy platform, which has successfully completed a Phase 2a study for relapsed/refractory... read more

Upcoming Events View all

September 8 - September 10, 2019

Rodman & Renshaw 21st Annual Global Investment Conference sponsored by H.C. Wainwright

December 4, 2019

Investor Breakfast 2019

January 13 - January 15, 2020

Biotech Showcase

I.R. Contacts

If you would like further information or have questions or comments, please contact:

Tim McCarthy
LifeSci Advisors, LLC

Media inquiries:

Tsipi Haitovsky
Public Relations